Established in November 2015, Biosensorix provides innovative diagnostic tools that enable fast and accurate life-saving decisions. We are focused on bringing quantitation to rapid and affordable point-of-care testing, thus allowing earlier and precise treatment that will benefit patients in developing countries and worldwide. Our initial technologies target dengue diagnosis and will extend to disease marker detection areas where quantitation is vital and currently unmet.
We are committed to saving lives and healthcare dollars, one patient at a time.